{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:11:18Z","timestamp":1790381478492,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40360-019-0327-5","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T14:02:40Z","timestamp":1565964160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo"],"prefix":"10.1186","volume":"20","author":[{"given":"Jean-Claude","family":"Makenga Bof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Muteba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mansiangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9licien","family":"Ilunga-Ilunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Coppieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,16]]},"reference":[{"key":"327_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/14787210.2017.1286980","volume":"4","author":"RA Cheke","year":"2017","unstructured":"Cheke RA. Factors affecting onchocerciasis transmission: lessons for infection control. Expert Rev Anti-Infect Ther. 2017;4:377\u201386.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"327_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1756-3305-7-98","volume":"7","author":"F Weldegebreal","year":"2014","unstructured":"Weldegebreal F, Medhin G, Weldegebreal Z, Legesse M. Assessement of community\u2019s knowledge, attitude and pratice about onchocerciasis and community directed treatment with Ivermectin in Quara District, north westem Ethiopia. Parasit Vectors. 2014;7:90\u20138.","journal-title":"Parasit Vectors"},{"key":"327_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1179\/000349802125000826","volume":"96","author":"ME Murdoch","year":"2002","unstructured":"Murdoch ME, Asuzu MC, Hagan M, Makunde WH, Ngoumou P, Ogbuagu KF, Okello D, Ozoh G, Remme J. Onchocerciasis: the clinical and epidemiologie burden of skin disease in Africa. Ann Top Med Parasitol. 2002;96:283\u201396.","journal-title":"Ann Top Med Parasitol"},{"key":"327_CR4","first-page":"1","volume":"11","author":"ME Murdoch","year":"2017","unstructured":"Murdoch ME, Murdoch IE, Evans J, Yahaya H, Njepuome N, Cousens S, Jones BR, Abiose A. Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea savanna. Northern Nigeria PLoS Negl Trop Dis. 2017;11:1\u201319.","journal-title":"Northern Nigeria PLoS Negl Trop Dis"},{"key":"327_CR5","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1080\/00034983.1998.11813363","volume":"92","author":"B Benton","year":"1998","unstructured":"Benton B. Economic impact of onchocerciasis control through the African program for onchocerciasis control: an overview. Ann Trop Med Parasitol. 1998;92:S33\u20139.","journal-title":"Ann Trop Med Parasitol"},{"key":"327_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.trstmh.2012.02.009","volume":"106","author":"YF Tchounkeu","year":"2012","unstructured":"Tchounkeu YF, Onyeneho NG, Wanji S, Kabali AT, Manianga C, Amazingo UV, Amuyunzu-Nyamongo M. Changes in stigma and discrimination of onchocerciasis in Africa. Trans R Soc Trop Med Hyg. 2012;106:340\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"327_CR7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jiph.2017.01.017","volume":"10","author":"Jean-Claude Makenga Bof","year":"2017","unstructured":"Makenga Bof J-C, Mpunga D, Soa EN, Ntumba F, Bakajika D, Murdoch ME, Coppieters Y. Onchocerciasis in the Democratic Republic of Congo: Survey of knowledge, attitude and perception in Bandundu province. Journal of Infection and Public Health. 2017;10:600-7.","journal-title":"Journal of Infection and Public Health"},{"key":"327_CR8","unstructured":"World Health Organisation (WHO) (2017) Unprecedented progress against neglected tropical diseases. WHO reports 2017; available at: \n                    http:\/\/www.who.int\/mediacentre\/news\/releases\/2017\/ntd-report\/fr\/\n                    \n                   [consulted on Dec 22, 2017]."},{"key":"327_CR9","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1371\/journal.pmed.0030371","volume":"3","author":"MG Bas\u00e1\u00f1ez","year":"2006","unstructured":"Bas\u00e1\u00f1ez MG, Churcher TS PSD, Breitling LP, Little MP, Boussinesq M. River blindness: a success story under threat? PLoS Med. 2006;3:1454\u201360.","journal-title":"PLoS Med"},{"key":"327_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1179\/136485908X337454","volume":"102","author":"M Sauerbrey","year":"2008","unstructured":"Sauerbrey M. The onchocerciasis elimination program for the Americas (OEPA). Ann Trop Med Parasitol. 2008;102:25\u20139.","journal-title":"Ann Trop Med Parasitol"},{"key":"327_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.actatropica.2016.06.017","volume":"162","author":"R Abdul-Ghani","year":"2016","unstructured":"Abdul-Ghani R, Mahdy MA, Beier JC. Onchocerciasis in Yemen: time to take action against a neglected tropical parasitic disease. Acta Trop. 2016;162:133\u201341.","journal-title":"Acta Trop"},{"key":"327_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1179\/136485908X337427","volume":"1","author":"B Boatin","year":"2008","unstructured":"Boatin B. The onchocerciasis control program in West Africa (OCP). Ann Trop Med Parasitol. 2008;1:13\u20137.","journal-title":"Ann Trop Med Parasitol"},{"key":"327_CR13","unstructured":"World Health Organisation (WHO) (2018) Disease Watch Focus: Onchocerciasis. WHO 2018. Available at: \n                    http:\/\/www.who.int\/tdr\/publications\/disease_watch\/oncho\/en\/\n                    \n                   [consulted on Jul 15, 2018]."},{"key":"327_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/tmi.12397","volume":"20","author":"J-C Makenga Bof","year":"2015","unstructured":"Makenga Bof J-C, Maketa V, Bakajika DK, Ntumba F, Mpunga D, Murdoch ME, Hopkins A, Noma MM, Zour\u00e9 H, Tekle AH, Katabarwa MN, Lutumba P. Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment. Trop Med Int Health. 2015;20:48\u201362.","journal-title":"Trop Med Int Health"},{"key":"327_CR15","unstructured":"Minist\u00e8re de la Sant\u00e9 Publique, Secr\u00e9tariat G\u00e9n\u00e9ral, RDC (2016). Programme National de Lutte contre les Maladies Tropicales N\u00e9glig\u00e9es. Plan Strat\u00e9gique de Lutte contre les Maladies Tropicales N\u00e9glig\u00e9es \u00e0 Chimioth\u00e9rapie Pr\u00e9ventive 2016\u20132020. Kinshasa, RDC p 1\u2013179."},{"key":"327_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.trstmh.2007.03.007","volume":"101","author":"BL Dimomfu","year":"2007","unstructured":"Dimomfu BL, Lubeji DK, Noma M, Beketeli A, Boussines M. Sociological study in three foci of Central Africa before the implementation of treatments with ivermectin (Mectizan). APOC Trans R Soc Trop Med Hyg. 2007;101:674\u20139.","journal-title":"APOC Trans R Soc Trop Med Hyg"},{"key":"327_CR17","first-page":"1","volume":"11","author":"A Samuel","year":"2016","unstructured":"Samuel A, Belay T, Yehalaw D, Taha M, Zemene E, Zeynudin A. Impact of six years community directed treatment with Ivermectin in the control of onchocerciasis. Western Ethiopia PLoS One. 2016;11:1\u20139.","journal-title":"Western Ethiopia PLoS One"},{"key":"327_CR18","unstructured":"World Health Organisation (WHO) (2015) Weekly epidemiological record. N\u00b049. 90:661\u2013680."},{"key":"327_CR19","unstructured":"World Health Organisation (WHO) (2018) African Program for Onchocerciasis Control (APOC). Community-directed treatment with ivermectin (CDTI). Available at: \n                    http:\/\/www.who.int\/apoc\/cdti\/en\/\n                    \n                   [consulted on March 24, 2018]."},{"key":"327_CR20","unstructured":"Mr Ahamadou Houna (2014) [Study of adverse effects of medicine used during the campaign against neglected tropical diseases] [in French]. Facult\u00e9 de m\u00e9decine et d\u2019odontostomatologie, Universit\u00e9 des sciences, des techniques et des technologiques, Bamako, R\u00e9publique du Mali. PhD, academic year 2013\u20132014."},{"key":"327_CR21","unstructured":"World Health Organisation (WHO) (2018) African Program for Onchocerciasis Control (APOC). Ivermectin. Available at: \n                    http:\/\/www.who.int\/apoc\/cdti\/ivermectin\/en\/\n                    \n                   [consulted on March 24, 2018]."},{"key":"327_CR22","first-page":"105","volume":"88","author":"M Ducorps","year":"1995","unstructured":"Ducorps M, Gardon-wendel N, Ranque S, Ndong W, Boussinesq M, Gardon J, Schneider D, Chippaux J-P. [Adverse reactions following ivermectin treatment in patients with high Loa loa parasitaemia] [in French]. Bull Soc Path. 1995;88:105\u201312.","journal-title":"Bull Soc Path"},{"key":"327_CR23","first-page":"47","volume":"71","author":"B Carme","year":"1991","unstructured":"Carme B, Ebiliki B, Mbitsi A, Eopin N. [Clinical trial of ivermectin for the treatment of low to moderate Loa loa microfilaraemia] [in French]. Ann. Soc. belge M\u00e9d Trop. 1991;71:47\u201350.","journal-title":"Ann. Soc. belge M\u00e9d Trop."},{"key":"327_CR24","first-page":"280","volume":"86","author":"J-P Chippaux","year":"1992","unstructured":"Chippaux J-P, Ernould J-C, Gardon J, Gardon-wendel N, Chandre F, Barberi N. Ivermectin treatment of loiasis. Trans Roy Soc Trop Med Hyg. 1992;86:280\u20139.","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"327_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/00034983.1994.11812842","volume":"88","author":"P Hovette","year":"1994","unstructured":"Hovette P, Debonne JM, Touze JE, Gaxotte P, Imbert P, Fourcade I, Laroche R. Efficacy of ivermectin treatment of Loa loa filariasis patients without microfilaraemias. Ann Trop Med Parasitol. 1994;88:93\u20134.","journal-title":"Ann Trop Med Parasitol"},{"key":"327_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4269\/ajtmh.1993.48.186","volume":"48","author":"Y Martin-Prevel","year":"1993","unstructured":"Martin-Prevel Y, Cosnefroy JY, Tshipamba P, Ngari P, Chodakewitz JA, Pinder M. Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis. Am J Trop Med Hyg. 1993;48:186\u201392.","journal-title":"Am J Trop Med Hyg"},{"key":"327_CR27","unstructured":"Paris I, Datry A, Durepaire R, Felix H, Gaxotte P, Danis M & Gentilini M (1991)\u2013 [Interest of ivermectin in the initial treatment of loiasis] [in French]. Presse M\u00e9d. 20: 1383\u20131393."},{"key":"327_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.4269\/ajtmh.1988.39.480","volume":"39","author":"D Richard-Lenoble","year":"1988","unstructured":"Richard-Lenoble D, Kombila M, Rupp EL, Pappayliou ES, Gaxotte P, Nguiri C, Aziz M. Ivermectin in loiasis and concomitant O. vulvulus and M. perstans infections. Am J Trop Med Hyg. 1988;39:480\u20133.","journal-title":"Am J Trop Med Hyg"},{"key":"327_CR29","first-page":"113","volume":"5","author":"Anonyme","year":"1991","unstructured":"Anonyme. Encephalitis following treatment of loiasis. WHO Drug information. 1991;5:113\u20134.","journal-title":"WHO Drug information"},{"key":"327_CR30","first-page":"127","volume":"5","author":"Anonyme","year":"1991","unstructured":"Anonyme. Ivermectin: a possible neurotoxicity. WHO Drug information. 1991;5:127\u20138.","journal-title":"WHO Drug information."},{"key":"327_CR31","unstructured":"Chippaux J P, Ducorps M, Ranque S, Gardon N, Boussinesq M, Ndong W, Fobi G, Schneider D, Cot S & Garcia A (1994)- Adverse reactions following ivermectin treatment in patients with high Loa loa parasitaemia. 43rd annual meeting, am. Soc. trop. Med. Hyg., Cincinnati, USA, nov. 13-17."},{"key":"327_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4269\/ajtmh.1993.49.1","volume":"49","author":"JP Chippaux","year":"1993","unstructured":"Chippaux JP, Garcia A, Ranque S, Schneider D, Boussinesq M, Cot S, Le Hesran JY, Cot M. Adverse reactions following ivermectin treatment in hyperendemic loiasis area, joint annual meeting of the am. Soc. trop. Med. Hyg. And the am. Soc. Parasitol., 31 oct.4 nov. 1993, Atlanta, USA, abstract in am. J Trop Med Hyg. 1993;49:1\u2013161.","journal-title":"J Trop Med Hyg"},{"key":"327_CR33","unstructured":"Ernould J C (1993) [Feasibility study of a collective treatment against Loa loa with ivermectin in two villages of South-Cameroon] [in French]. PhD, Faculty of Medecine, 1993, Universit\u00e9 de Nantes (France)."},{"key":"327_CR34","first-page":"1","volume":"2002","author":"National Program for Onchocerciasis Control (NPOC)","year":"2002","unstructured":"National Program for Onchocerciasis Control (NPOC). [Annual technical report of the National Coordination Group for onchocerciasis (NCGO)] [in French] Kasai occidental project. Kinshasa, DRC. 2002;2002:1\u201350.","journal-title":"Kinshasa, DRC"},{"key":"327_CR35","first-page":"1","volume":"2009","author":"National Program for Onchocerciasis Control (NPOC)","year":"2009","unstructured":"National Program for Onchocerciasis Control (NPOC). [Annual technical report of the National Coordination Group for onchocerciasis (NCGO)] [in French]. Bas Uel\u00e9 project, Kinshasa, DRC. 2009;2009:1\u201350.","journal-title":"Bas Uel\u00e9 project, Kinshasa, DRC"},{"key":"327_CR36","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.trstmh.2007.03.018","volume":"101","author":"J Kamgno","year":"2007","unstructured":"Kamgno J, Pion SD, Tejiokem MC, Twum-Danso NA, Thylefors B, Boussinesq M. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg\/kg) versus current standard dose (150 microg\/kg). Trans R Soc Trop Med Hyg. 2007;101:777\u201385.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"327_CR37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3855\/jidc.9881","volume":"12","author":"JC Makenga Bof","year":"2018","unstructured":"Makenga Bof JC, Ntumba F, Mpunga D, Paul Mansiangi P, Ilunga-Ilunga F, Coppieters Y. Evolution of areas and factors associated with no community-directed treatment with Ivermectin, Democratic Republic of Congo. J Infect Dev Ctries. 2018;12:771\u20139.","journal-title":"J Infect Dev Ctries"},{"key":"327_CR38","unstructured":"DRC Ministry of Public Health: National Program for Onchocerciasis Control (NPOC) (2017) \u201cSAE data\u201d, Kinshasa; DRC."},{"key":"327_CR39","unstructured":"DRC Ministry of Public Health: National Program for Onchocerciasis Control (NPOC) (2015): \u201c Rapid Assessment Procedure for Loiasis \u201d (RAPLOA) and the \u201c Rapid Epidemiological Assessment \u201d for Onchocerciasis (REA), Kinshasa; DRC."},{"key":"327_CR40","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0035-9203(98)91091-4","volume":"92","author":"JP Chippaux","year":"1998","unstructured":"Chippaux JP, Bouchit\u00e9 B, Boussinesq M, Ranque S, Baldet T, Demanou M. Impact of repeated large scale ivermectin treatments on the transmission of Loa loa. Trans R Soc Trop Med Hyg. 1998;92:454\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"327_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4269\/ajtmh.2008.78.546","volume":"78","author":"J Kamgno","year":"2008","unstructured":"Kamgno J, Boussinesq M, Labrousse F, Nkegoum B, Thylefors BI, Mackenzie CD. Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp. Am J Trop Med Hyg. 2008;78:546\u201351.","journal-title":"Am J Trop Med Hyg."},{"key":"327_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005576","volume":"11","author":"S Wanji","year":"2017","unstructured":"Wanji S, Eyong EJ, Tendongfor N, Ngwa CJ, Esuka EN, Kengne-Ouafo AJ, Datchoua-Poutcheu FR, Enyong P, Agnew D, Eversole RR, Hopkins A, Mackenzie CD. Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment. PLoS Negl Trop Dis. 2017;11:1\u201325.","journal-title":"PLoS Negl Trop Dis"},{"key":"327_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40801-017-0110-0","volume":"4","author":"D Nzolo","year":"2017","unstructured":"Nzolo D, Anto F, Hailemariam S, Bakajika D, Muteba D, Makenga JC, Mesia G, Nsibu C, Mampunza S, Tona G. Central and peripheral nervous system disorders following Ivermectin mass administration: a descriptive study based on the Democratic Republic of Congo pharmacovigilance system. Drugs Real World Outcomes. 2017;4:151\u20138.","journal-title":"Drugs Real World Outcomes"},{"key":"327_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1076\/0928-6586(200003)711-2FT027","volume":"7","author":"G Fobi","year":"2000","unstructured":"Fobi G, Gardon J, Santiago M, Ngangue D, Gardon-Wendel N, Boussinesq M. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaraemia. Ophthalmic Epidemiol. 2000;7:27\u201339.","journal-title":"Ophthalmic Epidemiol"},{"key":"327_CR45","first-page":"1635","volume":"56","author":"OA Otubanjo","year":"2008","unstructured":"Otubanjo OA, Adeoye GO, Ibidapo CA, Akinsanya B, Okeke P, Atalabi T, Adejai ET, Braide E. Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo state. Nigeria. Rev Biol Trop. 2008;56:1635\u201343.","journal-title":"Rev Biol Trop"},{"key":"327_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.actatropica.2013.03.019","volume":"127","author":"MM Homeida","year":"2013","unstructured":"Homeida MM, Malcolm SB, ElTayeb AZ, Eversole RR, Elassad AS, Geary TG, Ali MM, Mackenzie CD. The lack of influence of food and local alcoholic brew on the blood level of Mectizan\u00ae (ivermectin). Acta Trop. 2013;127:97\u2013100.","journal-title":"Acta Trop"},{"key":"327_CR47","first-page":"10784","volume":"133","author":"A Sparsa","year":"2006","unstructured":"Sparsa A, Bonnetblanc J-M, Peyrot I, Loustaud-Ratti V, Vidal E, B\u00e9dane C. Systemic adverse reactions with ivermectin treatment of scabies. Ann Dermatol Venereol. 2006;133:10784\u20137.","journal-title":"Ann Dermatol Venereol"},{"key":"327_CR48","unstructured":"Grotenhermen F (2004) [medicinal use of cannabis. A practical guide of cannabis and THC therapeutic uses] [in German] 2004, AT Verlag, Baden und M\u00fcnchen (Germany),1 - 192."},{"key":"327_CR49","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S1201-9712(03)90013-0","volume":"7","author":"WA Oyibo","year":"2003","unstructured":"Oyibo WA, Fagbenro-Beyioku AF. Adverse reactions following annual ivermectin treatment of onchocerciasis in Nigeria. Int J Infect Dis. 2003;7:156\u20139.","journal-title":"Int J Infect Dis"},{"key":"327_CR50","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1056\/NEJMoa1705026","volume":"377","author":"J Kamgno","year":"2017","unstructured":"Kamgno J, Pion SD, Chesnais CB, Bakalar MH, D'Ambrosio MV, Mackenzie CD, Nana-Djeunga HC, Gounoue-Kamkumo R, Njitchouang GR, Nwane P, Tchatchueng-Mbouga JB, Wanji S, Stolk WA, Fletcher DA, Klion AD, Nutman TB, Boussinesq M. A test-and-not-treat strategy for onchocerciasis in Loa loa-endemic areas. N Engl J Med. 2017;377:2044\u201352.","journal-title":"N Engl J Med"},{"key":"327_CR51","unstructured":"World Health Organisation (WHO) (1991) Settling problems related to alcohol (In French). WHO, Regional Publications, European Series, No. 32 ISBN 92 890 2123 3 ISSN 0250\u20138575."},{"key":"327_CR52","first-page":"495","volume":"109","author":"F Grotenhermen","year":"2012","unstructured":"Grotenhermen F, M\u00fcller-Vahl K. The therapeutic potential of Cannabis and cannabinoids. Dtsch Arztebl Int. 2012;109:495\u2013501.","journal-title":"Dtsch Arztebl Int"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-019-0327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-019-0327-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-019-0327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T23:16:40Z","timestamp":1597447000000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-019-0327-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,16]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1186\/s40360-019-0327-5","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,16]]},"assertion":[{"value":"28 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee, School of Public Health, University of Kinshasa.Data are property of DRC\u2019s Ministry of Health. They were collected in accordance with the ethical principles enacted by the Helsinki\u2019s Declaration among others oral consent, due to lower education\u2019s level of population, obtained in the local language for a better understanding in participation and approved by the Ethics Committee, School of Public Health, University of Kinshasa. There was no benefit to the data collection participants.Our study being retrospective, we guarantee the confidentiality of collected data as well as the analysis and results presentation in accordance with the ethical principles.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}